Advertisement

Molecular Medicine

, Volume 18, Issue 11, pp 1421–1429 | Cite as

Augmenter of Liver Regeneration (ALR) Is a Novel Biomarker of Hepatocellular Stress/Inflammation: In Vitro, In Vivo and In Silico Studies

  • Yoram Vodovotz
  • John Prelich
  • Claudio Lagoa
  • Derek Barclay
  • Ruben Zamora
  • Noriko Murase
  • Chandrashekhar R. Gandhi
Research Article

Abstract

The liver is a central organ involved in inflammatory processes, including the elaboration of acute-phase proteins. Augmenter of liver regeneration (ALR) protein, expressed and secreted by hepatocytes, promotes liver regeneration and maintains viability of hepatocytes. ALR also stimulates secretion of inflammatory cytokines (tumor necrosis factor [TNF]-α and interleukin [IL]-6) and nitric oxide from Kupffer cells. We hypothesized that ALR may be involved in modulating inflammation induced by various stimuli. We found that hepatic ALR levels are elevated at 24 h, before or about the same time as an increase in the mRNA expression of TNF-α and IL-6, after portacaval shunt surgery in rats. Serum ALR also increased, but significantly only on d 4 when pathological changes in the liver become apparent. In rats, serum ALR was elevated after intraperitoneal administration of lipopolysaccharide alone and in a model of gram-negative sepsis. Serum ALR increased before alanine aminotransferase (ALT) in endotoxemia and in the same general time frame as TNF-α and IL-6 in the bacterial sepsis model. Furthermore, mathematical prediction of tissue damage correlated strongly with alterations in serum ALR in a mouse model of hemorrhagic shock. In vitro, monomethyl sulfonate, TNF-α, actinomycin D and lipopolysaccharide all caused increased release of ALR from rat hepatocytes, which preceded the loss of cell viability and/or inhibition of DNA synthesis. ALR may thus serve as a potential diagnostic marker of hepatocellular stress and/or acute inflammatory conditions.

Notes

Acknowledgments

This work was supported by VA Merit Review 1I1BX001174 and NIH grants R01-DK54411 and R21AA020846 (CR Gandhi). We thank Adam Kichler for technical assistance.

The content of this article does not represent the views of the Department of Veterans Affairs or the U.S. Government.

References

  1. 1.
    Francavilla A, et al. (1994) Augmenter of liver regeneration: its place in the universe of hepatic growth factors. Hepatology. 20:747–57.CrossRefGoogle Scholar
  2. 2.
    Gandhi CR, et al. (1999) A fresh look at augmenter of liver regeneration (ALR) in rats. Hepatology. 29:1435–45.CrossRefGoogle Scholar
  3. 3.
    Thirunavukkarasu C, et al. (2008) Augmenter of liver regeneration: an important intracellular survival factor for hepatocytes. J. Hepatol. 48:578–88.CrossRefGoogle Scholar
  4. 4.
    Lisowsky T, Lee JE, Polimeno L, Francavilla A, Hofhaus G. (2001) Mammalian augmenter of liver regeneration protein is a sulfhydryl oxidase. Dig. Liver Dis. 33:173–80.CrossRefGoogle Scholar
  5. 5.
    Farrell SR, Thorpe C. (2005) Augmenter of liver regeneration: a flavin-dependent sulfhydryl oxidase with cytochrome c reductase activity. Biochemistry. 44:1532–41.CrossRefGoogle Scholar
  6. 6.
    Allen S, Balabanidou V, Sideris DP, Lisowsky T, Tokatlidis K. (2005) Erv1 mediates the Mia40-dependent protein import pathway and provides a functional link to the respiratory chain by shuttling electrons to cytochrome c. J. Mol. Biol. 353:937–44.CrossRefGoogle Scholar
  7. 7.
    Lange H, et al. (2001) An essential function of the mitochondrial sulfhydryl oxidase Erv1p/ALR in the maturation of cytosolic Fe/S proteins. EMBO Rep. 2:715–20.CrossRefGoogle Scholar
  8. 8.
    Klissenbauer M, Winters S, Heinlein UA, Lisowsky T. (2002) Accumulation of the mitochondrial form of the sulphydryl oxidase Erv1p/Alrp during the early stages of spermatogenesis. J. Exp. Biol. 205:1979–86.PubMedGoogle Scholar
  9. 9.
    Gandhi CR, Murase N, Starzl TE. (2010) Cholera toxin-sensitive GTP-binding protein-coupled activation of augmenter of liver regeneration (ALR) receptor and its function in rat Kupffer cells. J. Cell. Physiol. 222:365–73.CrossRefGoogle Scholar
  10. 10.
    Peitzman AB, et al. (1995) Hemorrhagic shock. Curr. Probl. Surg. 32:925–1002.CrossRefGoogle Scholar
  11. 11.
    Ring A, Stremmel W. (2000) The hepatic microvascular responses to sepsis. Semin. Thromb. Hemost. 26:589–94.CrossRefGoogle Scholar
  12. 12.
    Fausto N, Campbell JS, Riehle KJ. (2006) Liver regeneration. Hepatology. 43:S45–53.CrossRefGoogle Scholar
  13. 13.
    Michalopoulos GK. (2007) Liver regeneration. J. Cell. Physiol. 213:286–300.CrossRefGoogle Scholar
  14. 14.
    Thasler WE, et al. (2005) Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma. Histopathology. 47:57–66.CrossRefGoogle Scholar
  15. 15.
    Wang G, et al. (1999) Identification and characterization of receptor for mammalian hepatopoietin that is homologous to yeast ERV1. J. Biol. Chem. 274:11469–72.CrossRefGoogle Scholar
  16. 16.
    Dayoub R, et al. (2006) Regulation of polyamine synthesis in human hepatocytes by hepatotrophic factor augmenter of liver regeneration. Biochem. Biophys. Res. Commun. 345:181–7.CrossRefGoogle Scholar
  17. 17.
    Thasler WE, et al. (2006) Repression of cytochrome P450 activity in human hepatocytes in vitro by a novel hepatotrophic factor, augmenter of liver regeneration. J. Pharmacol. Exp. Ther. 316:822–9.CrossRefGoogle Scholar
  18. 18.
    Dayoub R, et al. (2011) Liver regeneration associated protein (ALR) exhibits antimetastatic potential in hepatocellular carcinoma. Mol. Med. 17:221–8.CrossRefGoogle Scholar
  19. 19.
    Lotze MT, et al. (2007) The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol. Rev. 220:60–81.CrossRefGoogle Scholar
  20. 20.
    Gandhi CR, et al. (2002) Portacaval shunt causes apoptosis and liver atrophy despite increases in endogenous levels of major hepatic growth factors. J. Hepatol. 37:340–8.CrossRefGoogle Scholar
  21. 21.
    Geller DA, et al. (1994) Differential induction of nitric oxide synthase in hepatocytes during endotoxemia and the acute-phase response. Arch. Surg. 129:165–71.CrossRefGoogle Scholar
  22. 22.
    Wan Y, et al. (1995) Role of lipopolysaccharide (LPS), interleukin-1, interleukin-6, tumor necrosis factor, and dexamethasone in regulation of LPS-binding protein expression in normal hepatocytes and hepatocytes from LPS-treated rats. Infect. Immun. 63:2435–42.PubMedPubMedCentralGoogle Scholar
  23. 23.
    Liu S, et al. (1998) Expression of CD14 by hepatocytes: upregulation by cytokines during endotoxemia. Infect. Immun. 66:5089–98.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Ahrenholz DH, Simmons RL. (1980) Fibrin in peritonitis. I. Beneficial and adverse effects of fibrin in experimental E. coli peritonitis. Surgery. 88:41–7.PubMedGoogle Scholar
  25. 25.
    Chow CC et al. (2005) The acute inflammatory response in diverse shock states. Shock. 24:74–84.CrossRefGoogle Scholar
  26. 26.
    Uemura T, Gandhi CR. (2001) Inhibition of DNA synthesis in cultured hepatocytes by endotoxin-conditioned medium of activated stellate cells is transforming growth factor-β and nitric oxideindependent. Br. J. Pharmacol. 133:1125–33.CrossRefGoogle Scholar
  27. 27.
    Thirunavukkarasu C, Watkins S, Gandhi CR. (2006) Mechanisms of endotoxin-induced nitric oxide, interleukin-6 and tumor necrosis factor-a production in activated rat hepatic stellate cells: role of p38MAPK. Hepatology. 44:389–98.CrossRefGoogle Scholar
  28. 28.
    Thirunavukkarasu C, Uemura T, Wang LF, Watkins SC, Gandhi CR. (2005) Normal rat hepatic stellate cells respond to endotoxin in LBP-independent manner to produce inhibitor(s) of DNA synthesis in hepatocytes. J. Cell. Physiol. 204:654–65.CrossRefGoogle Scholar
  29. 29.
    Mosmann T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J. Immunol. Methods. 65:55–63.CrossRefGoogle Scholar
  30. 30.
    Lundin C, et al. (2005) Methyl methanesulfonate (MMS) produces heat-labile DNA damage but no detectable in vivo DNA double-strand breaks. Nucleic Acids Res. 33:3799–811.CrossRefGoogle Scholar
  31. 31.
    Moffatt P, Plaa GL, Denizeau F. (1996) Rat hepatocytes with elevated metallothionein expression are resistant to N-methyl-N’-nitro-N-nitroso-guanidine cytotoxicity. Toxicol. Appl. Pharmacol. 136:200–7.CrossRefGoogle Scholar
  32. 32.
    Maddox JF, et al. (2010) Bacterial- and viralinduced inflammation increases sensitivity to acetaminophen hepatotoxicity. J. Toxicol. Environ. Health A. 73:58–73.CrossRefGoogle Scholar
  33. 33.
    Lisowsky T. (1992) Dual function of a new nuclear gene for oxidative phosphorylation and vegetative growth in yeast. Mol. Gen. Genet. 232:58–64.CrossRefGoogle Scholar
  34. 34.
    Giorda R, et al. (1996) Analysis of the structure and expression of the augmenter of liver regeneration (ALR) gene. Mol. Med. 2:97–108.CrossRefGoogle Scholar
  35. 35.
    Starzl TE, Porter KA, Putnam CW. (1975) Intraportal insulin protects from the liver injury of portacaval shunt in dogs. Lancet. 2:1241–6.CrossRefGoogle Scholar
  36. 36.
    Starzl TE, et al. (1979) Growth-stimulating factor in regenerating canine liver. Lancet. 1:127–30.CrossRefGoogle Scholar
  37. 37.
    Dayoub R, et al. (2010) Foxa2 (HNF-3beta) regulates expression of hepatotrophic factor ALR in liver cells. Biochem. Biophys. Res. Commun. 395:465–70.CrossRefGoogle Scholar
  38. 38.
    Huang C, Yang S, Geller DA, Stolz D, Gandhi CR. (2011) Interferon-β derived from endotoxin-stimulated hepatic stellate cells cause hepatocyte injury via JNK-mediated IRF-1 expression. FASEB J. 25:A794.11Google Scholar
  39. 39.
    Tanigawa K, Sakaida I, Masuhara M, Hagiya M, Okita K. (2000) Augmenter of liver regeneration (ALR) may promote liver regeneration by reducing natural killer (NK) cell activity in human liver diseases. J. Gastroenterol. 35:112–9.CrossRefGoogle Scholar
  40. 40.
    Parker SJ, Watkins PE. (2001) Experimental models of gram-negative sepsis. Br. J. Surg. 88:22–30.CrossRefGoogle Scholar
  41. 41.
    Vodovotz Y, et al. (2006) In silico models of acute inflammation in animals. Shock. 26:235–44.CrossRefGoogle Scholar
  42. 42.
    Vodovotz Y, An G. (2009) Systems Biology and Inflammation. In: Systems Biology in Drug Discovery and Development: Methods and Protocols. Yan Q Totowa, NJ (ed.). Springer Science & Business Media, pp. 181–201.Google Scholar
  43. 43.
    Yang R, et al. (2006) Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock. Mol. Med. 12:105–14.CrossRefGoogle Scholar
  44. 44.
    Cohen MJ, et al. (2009) Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion. Crit. Care. 13:R174.CrossRefGoogle Scholar
  45. 45.
    Nathan C, Sporn M. (1991) Cytokines in context. J. Cell. Biol. 113:981–6.CrossRefGoogle Scholar
  46. 46.
    Nathan C. (2002) Points of control in inflammation. Nature. 420:846–52.CrossRefGoogle Scholar
  47. 47.
    Wang H, et al. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science. 285:248–51.CrossRefGoogle Scholar
  48. 48.
    Yang H, et al. (2004) Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc. Natl. Acad. Sci. U. S. A. 101:296–301.CrossRefGoogle Scholar
  49. 49.
    Hagiya M, et al. (1994) Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc. Natl. Acad. Sci. U. S. A. 91:8142–6.CrossRefGoogle Scholar

Copyright information

© The Author(s) 2012

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it.

The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this license, visit (https://doi.org/creativecommons.org/licenses/by-nc-nd/4.0/)

Authors and Affiliations

  • Yoram Vodovotz
    • 1
    • 2
  • John Prelich
    • 4
  • Claudio Lagoa
    • 1
  • Derek Barclay
    • 1
  • Ruben Zamora
    • 1
    • 2
  • Noriko Murase
    • 1
    • 5
  • Chandrashekhar R. Gandhi
    • 1
    • 3
    • 5
    • 6
  1. 1.Department of SurgeryUniversity of PittsburghPittsburghUSA
  2. 2.Center for Inflammation and Regenerative ModelingMcGowan Institute for Regenerative MedicinePittsburghUSA
  3. 3.Department of PathologyUniversity of PittsburghPittsburghUSA
  4. 4.VA Pittsburgh Healthcare SystemPittsburghUSA
  5. 5.Thomas E. Starzl Transplantation InstituteUniversity of PittsburghPittsburghUSA
  6. 6.current affiliation: Department of SurgeryUniversity of CincinnatiCincinnatiUSA

Personalised recommendations